Russia & CIS
Key therapeutic categories
Glenmark began its operations in the region in 1980. Today we have a strong presence in markets like Russia, Ukraine, Uzbekistan and Kazakhstan. We market over 40 products in Russia, which is also our largest subsidiary in the region. Glenmark ranks among the Top 50 companies in the retail segment of the Russian pharmaceutical market and among the Top 15 derma companies in Russia. We are also one of the fast growing companies in Ukraine’s pharmaceutical market and have been recording good growth in Kazakhstan and Uzbekistan. Today we have established multiple strong brands in the region, such as Candid, Ascoril and Oflomil.